Vanda Pharmaceuticals (VNDA) Earnings Date, Estimates & Call Transcripts $5.29 -0.04 (-0.75%) Closing price 04:00 PM EasternExtended Trading$5.40 +0.12 (+2.17%) As of 04:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Vanda Pharmaceuticals Earnings Summary Vanda Pharmaceuticals announced Q2 2025 earnings on July 31, 2025, reporting an EPS of -$0.46, which missed analysts' consensus estimates of -$0.34 by $0.12. Quarterly revenue was reported to be $52.59 million, below the consensus estimate of $54.77 million. With a trailing EPS of -$1.13, Vanda Pharmaceuticals' earnings are expected to grow next year, from ($1.12) to ($0.27) per share. Upcoming Q3 Earnings DateNov. 5After Market ClosesEstimatedConsensus EPS (Jul. 31) -$0.34 Actual EPS (Jul. 31) -$0.46 Missed By -$0.12 Actual Revenue (Jul. 31) $52.59MQ2 2025 Earnings ResourcesQ2 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)VNDA Upcoming EarningsVanda Pharmaceuticals' Q3 2025 earnings is scheduled for Wednesday, November 5, 2025, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q3 2025 Earnings ReportPowered by Get Vanda Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Vanda Pharmaceuticals and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataVNDA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VNDA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Vanda Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue GuidanceQ1 20251-$0.52-$0.52-$0.52Q2 20251-$0.35-$0.35-$0.35Q3 20251-$0.31-$0.31-$0.31Q4 20251-$0.20-$0.20-$0.20 FY 2025 4 -$1.38 -$1.38 -$1.38 Q1 20261-$0.15-$0.15-$0.15Q2 20261$0.02$0.02$0.02Q3 20261$0.06$0.06$0.06Q4 20261$0.12$0.12$0.12 Vanda Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/5/2025(Estimated)-------7/31/2025Q2 2025-$0.34-$0.46 -$0.12-$0.46$54.77M$52.59M5/7/2025Q1 2025-$0.55-$0.50+$0.05-$0.50$45.13M$50.04M2/13/2025Q4 2024-$0.14-$0.08+$0.06-$0.08$51.00M$53.19M7/31/2024Q2 2024--$0.08--$0.08-$50.47M5/8/2024Q1 2024$0.05-$0.07 -$0.12-$0.07$48.50M$47.46M2/7/2024Q4 2023-$0.09-$0.04+$0.05-$0.04$37.00M$45.27M Vanda Pharmaceuticals Earnings - Frequently Asked Questions When is Vanda Pharmaceuticals' earnings date? Vanda Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 5th, 2025 based off last year's report dates. Learn more on VNDA's earnings history. What guidance has Vanda Pharmaceuticals issued on next quarter's earnings? Vanda Pharmaceuticals updated its FY 2025 earnings guidance on Thursday, July, 31st. The company issued revenue guidance of $210.0 million-$250.0 million, compared to the consensus revenue estimate of $227.7 million. Did Vanda Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Vanda Pharmaceuticals (NASDAQ:VNDA) missed the analysts' consensus estimate of ($0.34) by $0.12 with a reported earnings per share (EPS) of ($0.46). Learn more on analysts' earnings estimate vs. VNDA's actual earnings. How can I listen to Vanda Pharmaceuticals' earnings conference call? The conference call for Vanda Pharmaceuticals' latest earnings report can be listened to online. Listen to Conference Call How can I read Vanda Pharmaceuticals' conference call transcript? The conference call transcript for Vanda Pharmaceuticals' latest earnings report can be read online. Read Transcript How much revenue does Vanda Pharmaceuticals generate each year? Vanda Pharmaceuticals (NASDAQ:VNDA) has a recorded annual revenue of $203.47 million. How much profit does Vanda Pharmaceuticals generate each year? Vanda Pharmaceuticals (NASDAQ:VNDA) has a recorded net income of -$18.90 million. VNDA has generated -$1.13 earnings per share over the last four quarters. What is Vanda Pharmaceuticals' EPS forecast for next year? Vanda Pharmaceuticals' earnings are expected to grow from ($1.12) per share to ($0.27) per share in the next year. More Earnings Resources from MarketBeat Related Companies OPKO Health Earnings Dynavax Technologies Earnings Zenas BioPharma Earnings Innoviva Earnings Geron Earnings Myriad Genetics Earnings Lexicon Pharmaceuticals Earnings Verastem Earnings Rigel Pharmaceuticals Earnings Emergent Biosolutions Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Louis Vuitton Earnings Show Luxury Bull Market Isn’t Done YetGoldman Sachs Earnings Tell: Markets Seem OkayWhy Congress Is Buying Intuitive Surgical Ahead of Earnings3 Reasons to Buy Sprouts Farmers Market Ahead of EarningsTesla Earnings Loom: Bulls Eye $600, Bears Warn of $300Spotify Could Surge Higher—Here’s the Hidden Earnings SignalBerkshire-Backed Lennar Slides After Weak Q3 Earnings This page (NASDAQ:VNDA) was last updated on 10/21/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vanda Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vanda Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
